NIH-funded research R21 grant

Estimating treatment benefits of hormone therapy for men with prostate cancer

Official title: Individualized estimates of treatment benefit from hormone therapy for men with prostate cancer

Funded at University of Michigan at Ann Arbor · NIH-10739866 · Data updated 2026-11-12

This study is looking to help men with localized prostate cancer understand how hormone therapy might work for them by considering their unique health situations and backgrounds, so they can make better choices about their treatment.

More Prostate Cancer research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startSeptember 20, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$386,866
NIH project number1R21CA274500-01A1
Project IDNIH-10739866 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are men diagnosed with localized prostate cancer who are considering hormone therapy as part of their treatment.

Less likely to help

Patients with advanced prostate cancer or those who are not considering hormone therapy may not benefit from this research.

What this research studies

This research aims to create personalized estimates of treatment benefits from hormone therapy for men diagnosed with localized prostate cancer. By analyzing data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, the study focuses on understanding how other health conditions and demographics influence life expectancy and treatment outcomes. The goal is to develop a model that helps doctors and patients make informed decisions about hormone therapy based on individual risk factors and potential benefits.

Why it matters

Potential benefit: If successful, this research could lead to more tailored treatment plans for men with prostate cancer, improving their quality of life and survival rates.

How similar studies have gone: Previous research has shown promise in developing individualized treatment models for cancer patients, indicating that this approach could be effective.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Schipper, Matthew — University of Michigan at Ann Arbor
  • Study coordinator: Schipper, Matthew

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.